Search - tctmd.com

Displaying 421 - 425 of 425

Sort: Relevancy | Date

News Industry News

Novartis' new heart failure medicine LCZ696 approved by FDA to reduce risk of cardiovascular death and heart failure hospitalization; now called Entresto™ (sacubitril-valsartan)

July 07, 2015

News Daily News

心力衰竭会使ACS后的结果恶化，阿哌沙班不能带来益处

January 28, 2015

News Daily News

HF Worsens Outcomes Following ACS, With No Benefit From Apixaban

January 28, 2015

The Role of Atrial Shunts in the Treatment of HFpEF

CME

The Role of Atrial Shunts in the Treatment of HFpEF

State of the Art: Creating Left-to-Right Shunts as a Treatment for Chronic Heart Failure

CME

State of the Art: Creating Left-to-Right Shunts as a Treatment for Chronic Heart Failure

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.